RETRACTABLE TECHNOLOGIES INC (RVP)
US76129W1053 - Common Stock
Taking everything into account, RVP scores 3 out of 10 in our fundamental rating. RVP was compared to 193 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for RVP as it has an excellent financial health rating, but there are worries on the profitability. RVP has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
RVP had negative earnings in the past year.
In the past year RVP had a positive cash flow from operations.
RVP had positive earnings in 4 of the past 5 years.
Each year in the past 5 years RVP had a positive operating cash flow.
1.2 Ratios
RVP's Return On Assets of -4.04% is fine compared to the rest of the industry. RVP outperforms 63.21% of its industry peers.
RVP's Return On Equity of -7.30% is fine compared to the rest of the industry. RVP outperforms 63.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.04% | ||
| ROE | -7.3% | ||
| ROIC | N/A |
ROA(3y)8.49%
ROA(5y)11.39%
ROE(3y)17.82%
ROE(5y)23.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 20.90%, RVP is doing worse than 79.79% of the companies in the same industry.
In the last couple of years the Gross Margin of RVP has declined.
The Profit Margin and Operating Margin are not available for RVP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.9% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.67%
GM growth 5Y-7.37%
2. Health
2.1 Basic Checks
RVP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RVP has about the same amount of shares outstanding.
The number of shares outstanding for RVP has been reduced compared to 5 years ago.
RVP has a better debt/assets ratio than last year.
2.2 Solvency
RVP has an Altman-Z score of 1.04. This is a bad value and indicates that RVP is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.04, RVP perfoms like the industry average, outperforming 50.78% of the companies in the same industry.
RVP has a debt to FCF ratio of 0.80. This is a very positive value and a sign of high solvency as it would only need 0.80 years to pay back of all of its debts.
RVP has a Debt to FCF ratio of 0.80. This is amongst the best in the industry. RVP outperforms 92.23% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that RVP is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, RVP is in the better half of the industry, outperforming 65.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.8 | ||
| Altman-Z | 1.04 |
ROIC/WACCN/A
WACC9.6%
2.3 Liquidity
RVP has a Current Ratio of 8.28. This indicates that RVP is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.28, RVP belongs to the best of the industry, outperforming 87.05% of the companies in the same industry.
A Quick Ratio of 6.41 indicates that RVP has no problem at all paying its short term obligations.
The Quick ratio of RVP (6.41) is better than 82.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.28 | ||
| Quick Ratio | 6.41 |
3. Growth
3.1 Past
The earnings per share for RVP have decreased strongly by -274.54% in the last year.
RVP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -54.02%.
RVP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.54% yearly.
EPS 1Y (TTM)-274.54%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q96.65%
Revenue 1Y (TTM)-54.02%
Revenue growth 3Y-18.96%
Revenue growth 5Y5.54%
Revenue growth Q2Q12.69%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for RVP. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
RVP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. RVP is cheaper than 93.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.33 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
RVP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
RETRACTABLE TECHNOLOGIES INC
NYSEARCA:RVP (5/16/2024, 7:15:32 PM)
After market: 0.9802 +0 (+0.02%)0.98
-0.14 (-12.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap29.34M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.04% | ||
| ROE | -7.3% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.9% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 8.28 | ||
| Quick Ratio | 6.41 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-274.54%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-54.02%
Revenue growth 3Y-18.96%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y